Cite
HARVARD Citation
Kerbusch, T. et al. (2020). Exposure–response characterisation of tildrakizumab in chronic plaque psoriasis: Pooled analysis of 3 randomised controlled trials. British journal of clinical pharmacology. 86 (9), pp. 1795-1806. [Online].